Literature DB >> 20213697

Age at diagnosis of birth defects.

Carol Bower1, Edwina Rudy, Ann Callaghan, Jennifer Quick, Natasha Nassar.   

Abstract

BACKGROUND: Many birth defects surveillance programs ascertain cases of birth defects diagnosed beyond 1 year of age. The Western Australian (WA) Birth Defects Registry includes cases diagnosed up to 6 years of age, but the value of extending ascertainment beyond 1 year has not been assessed.
METHODS: We examined the age at diagnosis for all cases and all birth defects notified to the WA Birth Defects Registry for births and terminations of pregnancy in 2000 and 2001 and estimated the amount of person time needed to ascertain cases diagnosed beyond 1 year of age.
RESULTS: Of the 3294 cases of birth defects, 616 (18.7%) had at least one birth defect diagnosed prenatally, 1574 cases (47.8%) were first diagnosed by 1 month of age, 671 infants (20.4%) were first diagnosed with a birth defect from 1 month up to 1 year, and 400 cases (12.1%) were first diagnosed between 1 and 6 years of age. Two thirds of children diagnosed with Fetal Alcohol Syndrome, and one quarter of those with congenital hearing loss were diagnosed beyond 1 year of age. We estimated that it took 1.76 person weeks work per annum to ascertain cases diagnosed between 1 and 6 years of age.
CONCLUSIONS: One in eight cases of birth defects were ascertained beyond 1 year of age. We consider that the additional work required to include these cases in Western Australia is outweighed by the benefit of more complete ascertainment. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20213697     DOI: 10.1002/bdra.20658

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  16 in total

1.  Associated anomalies among infants with oral clefts at birth and during a 1-year follow-up.

Authors:  Monica Rittler; Viviana Cosentino; Jorge S López-Camelo; Jeffrey C Murray; George Wehby; Eduardo E Castilla
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

2.  A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.

Authors:  Erin Kelty; Gary Hulse
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

3.  Breech presentation at delivery: a marker for congenital anomaly?

Authors:  D Mostello; J J Chang; F Bai; J Wang; C Guild; K Stamps; T L Leet
Journal:  J Perinatol       Date:  2013-10-24       Impact factor: 2.521

4.  Drug safety in pregnancy: the German Embryotox institute.

Authors:  Katarina Dathe; Christof Schaefer
Journal:  Eur J Clin Pharmacol       Date:  2017-10-24       Impact factor: 2.953

5.  Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding.

Authors:  Sigal Kaplan; Mikhail Zeygarnik; Tal Stern
Journal:  Drug Saf       Date:  2022-03-16       Impact factor: 5.228

Review 6.  Translational potential of hiPSCs in predictive modeling of heart development and disease.

Authors:  Corrin Mansfield; Ming-Tao Zhao; Madhumita Basu
Journal:  Birth Defects Res       Date:  2022-03-09       Impact factor: 2.661

7.  Prevalence of orofacial clefts in Nigeria.

Authors:  A Butali; W L Adeyemo; P A Mossey; H O Olasoji; I I Onah; A Adebola; A Akintububo; O James; O O Adeosun; M O Ogunlewe; A L Ladeinde; B O Mofikoya; M O Adeyemi; O A Ekhaguere; C Emeka; T A Awoyale
Journal:  Cleft Palate Craniofac J       Date:  2013-04-04

8.  Off-label use of ondansetron in pregnancy in Western Australia.

Authors:  Lyn Colvin; Andrew W Gill; Linda Slack-Smith; Fiona J Stanley; Carol Bower
Journal:  Biomed Res Int       Date:  2013-12-12       Impact factor: 3.411

9.  National population-based estimates for major birth defects, 2010-2014.

Authors:  Cara T Mai; Jennifer L Isenburg; Mark A Canfield; Robert E Meyer; Adolfo Correa; Clinton J Alverson; Philip J Lupo; Tiffany Riehle-Colarusso; Sook Ja Cho; Deepa Aggarwal; Russell S Kirby
Journal:  Birth Defects Res       Date:  2019-10-03       Impact factor: 2.661

10.  Who Should Be Targeted for the Prevention of Birth Defects? A Latent Class Analysis Based on a Large, Population-Based, Cross-Sectional Study in Shaanxi Province, Western China.

Authors:  Zhonghai Zhu; Yue Cheng; Wenfang Yang; Danyang Li; Xue Yang; Danli Liu; Min Zhang; Hong Yan; Lingxia Zeng
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.